A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients
NCT05375136
·
clinicaltrials.gov ↗
COMPLETED
Status
135
Enrollment
INDUSTRY
Sponsor class
Conditions
Endometrial Neoplasms
Endometrium
Carcinoma
Renal Cell Carcinoma
Interventions
OTHER:
Non-interventional
Sponsor
Eisai Korea Inc.